DonaldPTashkinMD

PubMed

• Duration and Frequency of Spirometry Needed to Accurately Reflect Annualized Change of FEVin Chronic Obstructive Pulmonary Disease.
  Jared D Wilkinson, Holly Wilhalme, Christopher B Cooper, Igor Z Barjaktarevic, Donald P Tashkin
  Annals of the American Thoracic Society. 2024-12-01
• Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related inter...
  Sangmee Sharon Bae, Fereidoun Abtin, Grace Kim, Daniela Markovic, Cato Chan
  RMD Open. 2024-11-27
• Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung Volumes.
  Mehrdad Arjomandi, Siyang Zeng, Igor Barjaktarevic, Eugene R Bleecker, Russell P Bowler
  Annals of the American Thoracic Society. 2024-11-25

Journal Articles

• Ongoing Clinical Trials and Treatment Options for Patients with Systemic Sclerosis–Associated Interstitial Lung Disease  
  Donald P Tashkin, Dinesh Khanna, Rheumatology
• Relationship between quantitative radiographic assessments of interstitial lung disease and physiologic and clinical features of systemic sclerosis  
  Tashkin DP, Volkmann ER, Tseng C-H, Kin HJ, Goldin J, Clements P, Furst D, Khanna D, Kleerup E, Roth M, Elashoff R, Ann Rheum Dis, 1/1/2014
• Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard-ratio variation  
  Yang T, Chang P-Y, Parak SL, Bastani D, Chang S-C, Morgenstern H, Tashkin DP, Mao JT, Papp JC, Rao J-Y, Cozen W, Mack TM, Greenland S, Zhang Z-F, Cancer Causes and Control, 1/1/2014
• Chronic productive cough is associated with death in early COPD  
  Putcha N, Drummond M, Connett J, Scanlon P, Tashkin D, Hansel N, Wise R, COPD: Journal of Chronic Obstructive Pulmonary Disease, 1/1/2014
• Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD  
  Tashkin DP, Li N, Kleerup E, Halpin D, Celli B, Decramer M, Elashoff R, Respir Research, 1/1/2014
• Appraisal of ocular safety with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma  
  Maspero J, Cherrez I, Doherty DE, Tashkin DP, Kuna P, Kuo W-L, Gatres D, Nolte H, Chylack LT, Respiratory Medicine, 1/1/2014
• Limited generalisability of UPLIFT findings to clinical practice Correspondence: authors’ response to Walker et al  
  Tashkin DP, Metzdorf N, Hallmann C, Leimer I, Lee T, Decramer M, Thorax, 1/1/2014
• The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD)  
  Park HY, Man SFP, Tashkin D, Wise RA, Connett JE, Anthonisen NA, Sin DD, PLOS One, 1/1/2013
• Club cell protein 16 and disease progression in chronic obstructive pulmonary disease (COPD)  
  Park HY, Churg A, Wright J, Yuexin L, Tam S, Man S-F, Tashkin D, Wise R, Connett J, Sin D, Am J Respir Crit Care Med, 1/1/2013
• Effects of marijuana on the lung  
  Tashkin DP, Ann Am Thorac Soc, 1/1/2013
• Safety and efficacy of intravenous mesenchymal stem cell administration in patients with moderate-severe chronic obstructive pulmonary disease  
  Weiss DJ, Casaburi R, Flannery R, Williams M, Tashkin D, Chest, 1/1/2013
• Tiotropium for the treatment of Chronic Obstructive Pulmonary Disease  
  Tashkin DP, Clin Pract, 1/1/2013
• Perceptions and attitudes toward the use of nebulized therapy for COPD: Patient and caregiver perspectives  
  Sharafkhaneh A, Wolf RA, Goodnight S, Hanania NA, Make BJ, Tashkin DP, COPD: Journal of Chronic Obstructive Pulmonary Disease, 1/1/2013
• Variations in FEV1 decline over time in COPD and its implications  
  Tashkin DP, Curr Opin Pulm Med, 1/1/2013
• Roflumilast: The new orally active, selective phosphodiesterase-4 inhibitor for the treatment of COPD  
  Tashkin DP, Expert Opin Pharmacother, 1/1/2013
• Expert Opinion: How can quantitative CT benefit patients with COPD and idiopathic interstitial pneumonias? Editorial: Expert Opinion section  
  Boiselle PM, Crapo JD, Han MK, Lynch DA, Tashkin DP, J Thoracic Imaging, 1/1/2013
• The future of fixed-dose long-acting beta-agonist and long-acting antimuscarinic (LABA/LAMA) combination therapy in COPD?  
  Tashkin DP, Lancet, 1/1/2013
• Quality and reproducibility of spirometry in patients with COPD: The UPLIFT experience  
  Janssens W, Liu Y, Liu D, Kesten S, Tashkin DP, Celli BR, Decramer M, Respir Med, 1/1/2013
• Combination bronchodilator therapy in the management of COPD  
  Tashkin DP, Ferguson G, Respir Research, 1/1/2013
• Annual rates of change in pre- vs post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD  
  Tashkin DP, Li N, Halpin D, Kleerup E, Decramer M, Celli B, Elashoff R, Respiratory Medicine, 1/1/2013
• Design of the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)  
  The SPIROMICS Investigators, Thorax, 1/1/2013
• Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease  
  Celli B, Decramer M, Lystig T, Kesten S, Tashkin DP, Respiratory Research, 1/1/2012
• HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation  
  Baay-Guzman GJ, Bebenek IG, Zeidler M, Hernandez-Pando R, Vega MI, Garcia-Zepeda EA, Antonio-Andres G, Bonavida B, Riedl M, Kleerup E, Tashkin DP, Hankinson O, Huerta-..., Respiratory Research, 1/1/2012
• Spirometric predictors of lung function decline and mortality in early COPD  
  Drummond MB, Hansel NN, Connett JE, Ruczinski I, Scanlon PD, Tashkin DP, Wise RA, Am J Respir Crit Care Med, 1/1/2012
• Correlation of cough with disease activity and treatment with cyclosphosphamide in scleroderma interstitial lung disease  
  Theodore AC, Tseng C-H, Li N, Elashoff R, Tashkin DP, Chest, 1/1/2012
• Join now to see all

Books/Book Chapters

• Handbook of Cannabis and Related Pathologies 
  Chapter: Cannabis smoking and the lung. 
  Tashkin DPEditors: Preedy V.Elsevier2015
• Marijuana and Cannabinoids 
  Chapter: Effects of THC and Marijuana on the Lung and Immune System 
  Tashkin DP, RothEditors: M. Elsohly.Humana Press, Totowa, NJ2007
• Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential 
  Chapter: Respiratory Risks of Marijuana Smoking. 
  Page 387 - 390Tashkin DPEditors: F. Grotenhermen.Verlag Hans Huber & Haworth Press, BernEdition 2nd,2004
• The Role of the Distal Lung and Parenchyma in Asthma (based on Small Airway Group for Education [SAGE] Conference). 
  Chapter: Physiologic and radiographic assessmnt of changes in small airway function. 
  Page 6 - 12Tashkin DPNational Jewish Medical and Research Center, Denver, CO2003
• Raising the Standard in COPD Management. 
  Fabbri L, Decramer M, Grouse L, Jones P, O’Donnell D, Rodriguez-Roisin R, Rudolf M, Tashkin DShire Heath International, London, United Kingdom2002
• Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential 
  Chapter: Respiratory Risks from Marijuana Smoking. 
  Page 351 - 362Tashkin DPEditors: F. Grotenhermen.Verlag Hans Huber & Haworth Press, Bern2001
• Asthma and the Small Airways. 
  Chapter: Evaluation of Small Airways and the Impact of Inhaled Steroids. 
  Page 7 - 15Tashkin DPEditors: Wenzel SE, Monograph Editor, Peters SP.American Thoracic Society Continuing Education Monograph, American Thoracic Society, New York, NY2000
• Rehabilitation of the Patient with Respiratory Disease. 
  Chapter: Rehabilitation in the Asthma Population. Chapter 38. 
  Page 455 - 488Ellstrom K, Kleerup EC, Tashkin DPEditors: Cherniack N, Altose M, Homma I.McGraw Hill, New York, NY1999
• Marihuana and Medicine. 
  Chapter: Marihuana and the Lung. Chapter 20. 
  Page 279 - 287Tashkin DPEditors: Nahas GG, Sutin KM, Agurell S.Humana Press, Inc., Totowa, NJ1999
• Atlas of Office Procedures (Respiratory Procedures) Volume 2, No. 3 
  Chapter: Metered Dose Inhalers. 
  Page 407 - 419Ellstrom K, Kleerup EC, Tashkin DPEditors: CG Elliott.W.B. Saunders Co., Philadelphia, PA1999
• The Health Effects of Cannabis 
  Chapter: Cannabis effects on the respiratory system. 
  Page 313 - 345Tashkin DPEditors: H. Kalant, W. Corrigall, W. Hall, R. Smart.The Addiction Research Foundation, Centre for Addiction and Mental Health, Toronto, Canada1999
• The Role of Antileukotrienes in Clinical Practice. Asthma 2000 Monograph Series. 
  Chapter: Safety and efficacy of leukotriene modifiers. Asthma 2000. 
  Page 25 - 36Simon RA, Tashkin DPWestern Regional Monograph, Discovery International, Deerfield, IL1999
• The Health "Effects of Cannabis. 
  Chapter: Effects of cannabis on the respiratory system. 
  Tashkin DPEditors: Kalant H, Corrigal W, Hall W, Smart R.Addiction Research Foundation, Toronto, Canada1998
• Secretary's Youth Substance Abuse Prevention Initiative. Regional Technical Assistance Workshop. 
  Chapter: Effects of marijuana on the lung and its immune defenses. 
  Page 33 - 51Tashkin DPCenter for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration, USDHHS, Washington, DC1997
• Allergy, Clinical Immunology and Asthma: Management in Infants, Children and Adults 
  Chapter: Chronic obstructive pulmonary diseases in adults. 
  Page 600 - 612Kleerup E, Tashkin DPEditors: Bierman CW, Pearlman DS, Shapiro GC, Busse WW.W.B. Saunders Co., Philadelphia, PA1995
• Provocative Challenge 
  Chapter: Bronchodilators as a bronchial challenge. 
  Page 513 - 573Tashkin DPEditors: Spector S.Marcel Dekker, Inc., New York, NY1994
• Provocative Challenge 
  Chapter: Bronchial hyperresponsiveness in chronic obstructive pulmonary disease. 
  Page 575 - 598Tashkin DPEditors: Spector S.Marcel Dekker, Inc., New York, NY1994
• Manual of Clinical Immunology and Allergy. 
  Chapter: Asthma. 
  Lawler GL, Tashkin DPEditors: Lawlor GL.Little, Brown andCompany, Boston, MAEdition 3rd,1994
• Bronchial Asthma: Mechanisms and Therapeutics. 
  Chapter: Beta-adrenergic agonists. 
  Page 700 - 748Tashkin DP, Jenne JJEditors: Weiss ER, Stein M.Little, Brown andCompany, Boston, MAEdition 3rd,1993
• Cocaine: Physiological and Physiopathological Effects 
  Chapter: Respiratory effects of cocaine freebasing among habitual cocaine users. 
  Tashkin DP, Gorelick D, Khalsa M-E, Simmons M, Chang PEditors: Paredes A, Gorelick DA.Haworth Press, New York, NY1992
• The UCLA population studies of CORD. X. A cohort study of changes in respiratory function associated with chronic exposure to SOX, NOX and hydrocarbons. 
  Detels R, Tashkin DP, Sayre JW, Rokaw SN, Massey FJ, Coulson AH, Wegman DH1991
• Biochemistry and Physiology of Substance Abuse III 
  Chapter: Marijuana and lung function. 
  Page 41 - 69Tashkin DPEditors: RR Watson.CRC Press, Boca Raton, FL1991
• Research Findings on Smoking of Abused Substances, NIDA Research Monograph #99 
  Chapter: Effects of habitual use of marijuana and/or cocaine on the lung. 
  Page 63 - 87Tashkin DP, Fligiel S, Wu T-C, Gong H Jr, Barbers RG, Coulson AH, Simmons MS, Beals TFDHHS Publication No. (ADM) 90-1690, Alcohol, Drug Abuse, and Mental Health Administration, U.S. Government printing office, Washington, DC1990
• Manual of Acute Respiratory Care. 
  Chapter: Acute Ventilatory Failure in Chronic Obstructive Pulmonary Disease. 
  Tashkin DPEditors: Zagelbaum GL, Pare JA, Simmons DH.Little, Brown andCompany, Boston, MAEdition 2nd,1990
• Manual of Acute Respiratory Care. 
  Chapter: Asthma 
  Wallace J, Tashkin DPEditors: Zagelbaum GL, Pare JA, Simmons DH.Little, Brown andCompany, Boston, MAEdition 2nd,1990
• Join now to see all

Abstracts/Posters

• Pulmonary toxicity from smoked illlicit and recreational drug use. Invited oral presentation
  Tashkin DP, CHEST, the Annual Meeting of the American College of Chest Physicians, Austin, TX, 1/1/2014
• Effect of budesonide/formoterol or formoterol on exacerbation rates (including and excluding antibiotics) and responder analysis: Pooled analysis of chronic obstructiv...
  Tashkin DP, et al, CHEST, the Annual Meeting of the American College of Chest Physicians, Austin, TX, 1/1/2014
• Effect of budesonide/formoterol or formoterol on lung function and patient-centered outcomes: Pooled analysis of chronic obstructive pulmonary disease patients with mo...
  Tashkin DP, et al, CHEST, the Annual Meeting of the American College of Chest Physicians, Austin, TX, 1/1/2014
• Once-daily tiotropium Respimat add-on to ICS+LABA reduces risk of severer exacerbation and asthma worsening in patients with asthma, independent of degree of airflow o...
  Tashkin DP, et al, CHEST, the Annual Meeting of the American College of Chest Physicians, Austin, TX, 1/1/2014
• Rate of comorbidities during the 4-year UPLIFT trial in COPD: A post-hoc analysis. Oral presentation
  Tashkin DP, et al, CHEST, the Annual Meeting of the American College of Chest Physicians, Austin, TX, 1/1/2014
• Tiotropium delivered via Handihaler or Respimat: Improvement in health-related quality of life in patients with chronic obstructive pulmonary disease.
  Tashkin DP, et al, CHEST, the Annual Meeting of the American College of Chest Physicians, Austin, TX, 1/1/2014
• Scleroderma Lung: What it is and What do do about it.
  Clements P, Tashkin D, UCLA Department of Medicine Grand Rounds, Los Angeles, CA, 1/1/2014
• Safety of tiotropium in renally impaired patients.
  Tashkin DP, Metzdorf N, Hallmann C, Konen-Bergmann M, Kupas K, Dahl R, European Respiratory Society Annual Congress, Munich, Germany, 1/1/2014
• Impact of habitual marijuana (MJ) use on humoral and cellular immune response to a hepatitis B virus (HBV) vaccine.
  Kiertscher SM, Harui A, Ibrahim G, Tashkin DP, Roth MD, 20th Scientific Conference of the Society on Neuroimmune Pharmacology, New Orleans, LA, 1/1/2014
• Progressive deterioration of patients with scleroderma with pulmonary involvement: 11-year outcomes from the Scleroderma Lung Study (SLS I).
  Sullivan K, Furst D, Moriuchi L, Rho J, Pinckney A, Keyes-Elstein L, Tashkin D, 3rd Systemic Sclerosis World Congress, Rome, Italy, 1/1/2014
• Development of a composite outcome measure for systemic sclerosis-related interstitial lung disease.
  Volkmann E, Li N, Tashkin DP, Elashoff R, 3rd Systemic Sclerosis World Congress, Rome, Italy, 1/1/2014
• Effects of Long-Term Treatment with Budesonide/Formoterol (BUD/FM) Deliverd By Pressurized Metered-Dose Inhaler (pMDI) on Symptoms In African Americans and Caucasians ...
  Brown R, Tashkin D, Chipps B, Trudo F, American Academy of Asthma, Allergy and Immunology Annual Meeting, San Diego, CA, 1/1/2014
• Therapeutic equivalence of budesonide/formoterol (BUD/FM) breath-actuated inhaler (BAI) compared with BUD/FM pressurized metered-dose inhaler (pMDI) in adults and adol...
  Tashkin DP et al, American Academy of Asthma, Allergy and Immunology Annual Meeting, San Diego, CA, 1/1/2014
• Tiotropium Handihaler and Respimat in COPD: A safety analysis of pooled data.
  Halpin DMG, Dahl R, Hallmann C, Leimer I, Kupas K, Mueller A, Tashkin DP, American Thoracic Society International Conference, San Diego, CA, 1/1/2014
• The relationship between spirometry, air trapping and dyspnea in SPIROMICS: A study of patienits with COPD.
  Kanner RE, Hoffman E, Tashkin DP, American Thoracic Society International Conference, San Diego, CA, 1/1/2014
• Prediction of differences between FVC and SVC in COPD participants and controls from SPIROMICS.
  Kleerup EC, Paul T, Kim HJG, Kaplan A, Tashkin DP, Goldin JG, Cooper CB, American Thoracic Society International Conference, San Diego, CA, 1/1/2014
• Quantitative HRCT and pulmonary function assessments of response to inhaled versus nebulized long acting bronchodilators in COPD.
  Paul TK, Kim HJG, Lu P, Tashkin DP, Zeidler MR, Wang TS, Goldin JG, Cooper CB, Kleerup EC, American Thoracic Society International Conference, San Diego, CA, 1/1/2014
• Relationship between COPD severity, ICS use, and risk of pneumonia.
  Rennard SI, Sin D, Tashkin DP, Calverley PM, Radner F, American Thoracic Society International Conference, San Diego, CA, 1/1/2014
• Long-term Trends In Acute Bronchodilator Responses Over 4 Years In Patients With Mild/Moderate To Very Severe COPD: Post-Hoc Analysis Of Data From The UPLIFT Trial.
  Tashkin DP, Li N, Kleerup E, Halpin D, Decramer M, Celli B, Elashoff R, American Thoracic Society International Conference, San Diego, CA, 1/1/2014
• Effect Of Budesonide/Formoterol (BUD/FM) Versus FM Alone On The Rate Of Exacerbations (Either Including Or Excluding The Use Of Antibiotics As Part Of Exacerbation Def...
  Tashkin DP, Rennard S, Trudo F, et al, American Thoracic Society International Conference, San Diego, CA, 1/1/2014
• Trudo F, Rennard SI, Uryniak T, Tashkin DP, American Thoracic Society International Conference, San Diego, CA, 1/1/2014
• Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT trial.
  Decramer M, Celli B, Metzdorf N, Leimer I, Tashkin DP, Annual Congress of the European Respiratory Society, Barcelona, Spain, 1/1/2013
• Efficacy of tiotropium in a 4-year study analyzed according to new GOLD ABCD severity grading.
  Decramer M, Celli B, Tashkin D, Martin A, Leimer I, Metzdorf N, Halpin D, Annual Congress of the European Respiratory Society, Barcelona, Spain, 1/1/2013
• Relationship between COPD severity, ICS use and risk of pneumonia.
  Rennard S, Sin D, Tashkin D, Calverley P, Radner F, Naya I, Annual Congress of the European Respiratory Society, Barcelona, Spain, 1/1/2013
• Medical Marijuana: Helpful or Harmful.
  Tashkin DP, Freisthler B, Steel SJ, Weitzberg J, Science Matters, California Science Center, Los Angeles, CA, 1/1/2013
• Join now to see all

Lectures

• Phenotypic characteristics that help defilne response to therapy in patients with asthma and COPD. Invited oral presentation 
  Atlanta, GA - 1/1/2014
• Increasing marijuana use: What are the risks for lung health. Invited Network Featured Lecture 
  Austin, TX - 1/1/2014
• Effective asthma control: Challenges and guidelines. 
  Houston, TX - 1/1/2014
• COPD: Diagnosis and management and relation to HIV. Invited CME presentation 
  Los Angeles, CA - 1/1/2014
• New drugs and other technologies for COPD patients. 
  Los Angeles, CA - 1/1/2014
• Treating the newly diagnosed COPD patient. Invited speaker 
  Munich, Germany - 1/1/2014
• Smoking cessation and standard pharmacological therapies in COPD. 
  San Diego, CA - 1/1/2014
• Efficacy of tiotropiium over 4 years analyzed according to the new GOLD ABCD combined assessment classification. Invited Presentation 
  Cesme, Turkey - 1/1/2013
• Insights from the Scleroderma Lung Study. Invited Presentation 
  Los Angeles, CA - 1/1/2013
• Nebulization for the maintenance treatment of COPD. When, Why and Where? A Mini-theater Presentation 
  Philadelphia, PA - 1/1/2013
• New inhaled drugs and delivery devices for COPD treatment: focus on the Respimat. Invited Presentation 
  Tokyo, Japan - 1/1/2013
• Efficacy of tiotropium in COPD and impact on mortality based on the results of the UPLIFT trial. Invited Presentation 
  Tokyo, Japan - 1/1/2013
• Efficacy of tiotorpium in reducing exacerbations of COPD based on the results of the UPLIFT trial and a one-year trial of tiotropium in the Respimat Soft Mist Inhaler.... 
  Tokyo, Japan - 1/1/2013
• Effects of marijuana smoking on the lung. Invited Presentation 
  Vancouver, Canada - 1/1/2013
• Methods to improve outcomes in patients with COPD. 
  1/1/2013
• Clinical impact of quantitative CT measurements. Invited Presentation 
  Huntington Beach, CA - 1/1/2012
• Putting it all together: From physiology to interpretation. 
  Orlando, FL - 1/1/2012
• Is the annual rate of decline in FEV1 a useful marker of disease progression in COPD? Invited Presentation 
  St. Louis University, St. Louis, MO - 1/1/2012
• Does regular marijuana smoking lead to pulmonary disease (COPD, lung cancer, pneumonia, TB)? 
  University of California, San Francisco, CA - 1/1/2012
• Understanding and managing COPD: State of the Art in 1999. 
  Vienna, Austria - 1/1/2012
• Prevalence of pneumonia in chronic obstructive pulmonary disease. 
  Vienna, Austria - 1/1/2012
• Scleroderma-Related Interstitial Lung Disease: Lessons from the Scleroderma Lung Study. 
  Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO - 1/1/2011
• Similarities and differences between asthma and COPD: Impact on treatment. 
  Beijing, China - 1/1/2011
• Lessons learned from large-scale clinical trials: UPLIFT. Invited Presentation at COPD7USA. 
  Crystal City, VA - 1/1/2011
• New pharmacotherapies for COPD. Invited Presentation at COPD7USA. 
  Crystal City, VA - 1/1/2011
• Join now to see all

Other

• The effects of marijuana smoking on the lung; medical marijuana – societal perspective. 
  Tashkin DP, Ware M, Schraufnagel, American Thoracic Society
  1/1/2013
• Key features distinguishing COPD and asthma (CIRCULATE Peer-to Peer Podcast) 
  Tashkin DP, France Foundation
  1/1/2010
• The importance of exacerbations in COPD (CIRCULATE Peer-to-Peer Podcast) 
  Tashkin DP, Sethi S, France Foundation
  1/1/2010
• Emerging trends in asthma management: A focus on IgE. Newsletter summarizing a symposium of the same title held furing the 97th International Conference of the ATS, Ma... 
  Fick RB, Fish JE, Holgate ST, Tashkin DP
  1/1/2001
• Pulmonary Pathophysiologic and Immune Consequences of Smoked Substance Abuse. Electronic Program Book 
  Co-Chairs: Donald P. Tashkin, M.D.; Michael D. Roth, M.D.; and Pushpa V. Thadani, Ph.D., NIDA/NIH
  http://www.nida.nih.gov/MeetProg2.html#program
  1/1/2000
• Cocaine and Marijuana's Effects on the Airways. (Published Interview) 
  Journal of Respiratory Care Practitioners
  1/1/1997
• Medical Uses of Marijuana. (Published Interview) 
  Patient Care
  1/1/1997
• Participating scientist in video production of "Marijuana: The Mirror that Magnifies," an instructional documentary on the health effects of marijuana. 
  Tashkin DP, CNS Productions, Inc.
  Ashland, OR - 1/1/1996
• Participating scientist in video production of one in a series of productions, "What is Your Poison?", a documentary on the effects of marijuana on the lungs and other... 
  Tashkin DP, Quantum Productions, Australian Broadcasting Corp
  Sydney, Australia - 1/1/1996
• Try Capsules, Not Medicinal Marijuana. Editorials/Letters 
  Tashkin DP, New York Times
  1/18/1994
• Diagnosis and Management of Adult Asthma and Chronic Obstructive Pulmonary Disease. Monograph. 
  Tashkin DP, Boehrenger-Ingelheim Pharmaceuticals, Inc.
  Boston, MA - 1/1/1991
• Marijuana '87. Summary of the Session on Pulmonary Effects. Marijuana: An International Research Report. Proceedings of Melbourne Symposium on Cannabis 2-4 September... 
  Tashkin DP, Australian Government Publishing Service
  Canberra - 1/1/1988
• Diagnosis and Management of Adult Asthma and Chronic Obstructive Pulmonary Disease: A Computer-simulated Program and Companion Brochure for Physicians. 
  Tashkin DP, ROM Communications, Inc.
  New York, NY - 1/1/1988
• Asthma Control and Management: A Patient Education Slide - Cassette Presentation 
  Barbers R, Gong H, Tashkin DP, Wallace J, Ulmer R, UCLA Office of Instructional Development, Media Productions
  UCLA Asthma Center - 1/1/1988
• Join now to see all